These verities were determined in our study, where a marked decline in hippocampal LAMP2A content in AD rats was associated by enhanced NLRP3/cleaved caspase-1/ IL-1β and IL-18 trajectory. This evidence concerns the gene NLRP3 and Alzheimer disease.